Moderna (MRNA) Receivables (2017 - 2026)
Moderna's Receivables was $17 million in Q2 2026, down 82.5% from $97 million a year earlier and down 76.1% from the prior quarter.
Powered by 
Analysis
Moderna (MRNA) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Moderna came in at $184 million, down 51.3% from FY2024.
- Receivables has now declined for four consecutive years, with a five-year compound annual growth rate of -33.3% (FY2020 to FY2025).
- In earlier years, Receivables was $378 million in FY2024 (-57.6%), $892 million in FY2023 (-35.6%), $1.39 billion in FY2022 (-56.4%) and $3.18 billion in FY2021 (+128.3%).
- The Q2 2026 figure marks the lowest quarterly Receivables since Q1 2020.
- Compared with a year earlier, Receivables has declined for 16 straight quarters, with an average decline of 42.0% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q4 2021 (growth of 128.3%); the worst was Q2 2023 (a decline of 91.4%).
- Per Business Quant data, MRNA's Receivables in the three quarters before Q2 2026 was $71 million (Q1 2026), $184 million (Q4 2025) and $1.05 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 17.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.00 Mn |
| Mar 31, 2026 | 71.00 Mn |
| Dec 31, 2025 | 184.00 Mn |
| Sep 30, 2025 | 1.05 Bn |
| Jun 30, 2025 | 97.00 Mn |
| Mar 31, 2025 | 110.00 Mn |
| Dec 31, 2024 | 378.00 Mn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 163.00 Mn |
| Mar 31, 2024 | 137.00 Mn |
| Dec 31, 2023 | 892.00 Mn |
| Sep 30, 2023 | 1.87 Bn |
| Jun 30, 2023 | 232.00 Mn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 2.70 Bn |
| Jun 30, 2022 | 2.69 Bn |
| Mar 31, 2022 | 3.17 Bn |
| Dec 31, 2021 | 3.18 Bn |
| Sep 30, 2021 | 3.14 Bn |
API Access
Moderna Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=MRNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();